Journal of Neural Transmission

, Volume 116, Issue 7, pp 875–880

Valsalva manoeuvre in patients with different Parkinsonian disorders

  • C. Schmidt
  • B. Herting
  • S. Prieur
  • S. Junghanns
  • K. Schweitzer
  • C. Globas
  • L. Schöls
  • H. Reichmann
  • D. Berg
  • Tjalf Ziemssen
Movement Disorders - Original Article

Abstract

The valsalva manoeuvre (VM), used as an autonomic function test, can detect sympathetic and/or parasympathetic autonomic dysfunction. This study investigated the value of VM in patients with different Parkinsonian syndromes (PS). We continuously recorded blood pressure, ECG and respiration among 38 patients with multiple system atrophy (MSA), 32 patients with progressive supranuclear palsy (PSP), 26 patients with idiopathic Parkinson’s disease (PD) and in 27 healthy subjects matched in age and sex (Con). VM was performed in addition to metronomic breathing and tilt-table testing. VM could not be analysed in 26% of the ES patients. Valsalva ratio (VR), as a parameter of cardiovagal function, was pathologically decreased in all patient groups. Valsalva ratio (VR) was not able to discriminate parasympathetic dysfunction between patients and controls as well as E/I ratio of metronomic breathing. As a parameter of sympathetic dysfunction during VM, the physiological increase of blood pressure was more often missing during phase IV than phase II especially in PD and MSA patients. Correlation with orthostatic hypotension during tilt-table testing was only moderate. Although VM can demonstrate sympathetic and parasympathetic autonomic dysfunction, we cannot recommend VM as a first line autonomic test in PS patients. Metronomic breathing and tilt-table test seem more capable as parasympathetic resp. and sympathetic function tests to identify cardiovascular abnormalities in PS patients.

Keywords

Valsalva manoeuvre Autonomic dysfunction Parkinson’s disease Multiple system atrophy Progressive supranuclear palsy 

References

  1. Bouhaddi M, Vuillier F, Fortrat JO, Cappelle S, Henriet MT, Rumbach L, Regnard J (2004) Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson’s disease: involvement of l-dopa therapy. Auton Neurosci 116:30–38PubMedCrossRefGoogle Scholar
  2. Freeman R (2006) Assessment of cardiovascular autonomic function. Clin Neurophysiol 117:716–730PubMedCrossRefGoogle Scholar
  3. Friedrich C, Rüdiger H, Schmidt C, Herting B, Prieur S, Junghanns S, Schweitzer K, Globas C, Schöls L, Berg D, Reichmann H, Ziemssen T (2008) Baroreflex sensitivity and power spectral analysis in different extrapyramidal syndromes. J Neural Transmission 115:1527–1536CrossRefGoogle Scholar
  4. Gilman S, Low P, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, Kaufmann H, Klockgether T, Lang A, Lantos P, Litvan I, Mathias C, Oliver E, Robertson D, Schatz I, Wenning G (1998) Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res 8:359–362PubMedCrossRefGoogle Scholar
  5. Goldstein DS (2003) Dysautonomia in Parkinson’s disease: neurocardiological abnormalities. Lancet Neurol 2:669–676PubMedCrossRefGoogle Scholar
  6. Goldstein DS, Pechnik S, Holmes C, Eldadah B, Sharabi Y (2003) Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension 42:136–142PubMedCrossRefGoogle Scholar
  7. Goldstein DS, Eldadah BA, Holmes C, Pechnik S, Moak J, Saleem A, Sharabi Y (2005) Neurocirculatory abnormalities in Parkinson disease with orthostatic hypotension: independence from levodopa treatment. Hypertension 46:1333–1339PubMedCrossRefGoogle Scholar
  8. Gutrecht JA (1992) Autonomic cardiovascular reflexes in progressive supranuclear palsy. J Auton Nerv Syst 39:29–35PubMedCrossRefGoogle Scholar
  9. Hilz MJ, Dutsch M (2006) Quantitative studies of autonomic function. Muscle Nerve 33:6–20PubMedCrossRefGoogle Scholar
  10. Holmberg B, Kallio M, Johnels B, Elam M (2001) Cardiovascular reflex testing contributes to clinical evaluation and differential diagnosis of Parkinsonian syndromes. Mov Disord 16:217–225PubMedCrossRefGoogle Scholar
  11. Kimber J, Mathias CJ, Lees AJ, Bleasdale-Barr K, Chang HS, Churchyard A, Watson L (2000) Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy. Brain 123(Pt 7):1422–1430PubMedCrossRefGoogle Scholar
  12. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9PubMedGoogle Scholar
  13. Looga R (2005) The Valsalva manoeuvre—cardiovascular effects and performance technique: a critical review. Respir Physiol Neurobiol 147:39–49PubMedCrossRefGoogle Scholar
  14. Low PA (1993) Laboratory evaluation of autonomic failure. In: Low PA (ed) Clinical autonomic disorders. Little, Brown and Company, Boston, pp 169–196Google Scholar
  15. Mesec A, Sega S, Kiauta T (1993) The influence of the type, duration, severity and levodopa treatment of Parkinson’s disease on cardiovascular autonomic responses. Clin Auton Res 3:339–344PubMedCrossRefGoogle Scholar
  16. Oka H, Morita M, Onouchi K, Yoshioka M, Mochio S, Inoue K (2007a) Cardiovascular autonomic dysfunction in dementia with Lewy bodies and Parkinson’s disease. J Neurol Sci 254:72–77PubMedCrossRefGoogle Scholar
  17. Oka H, Yoshioka M, Onouchi K, Morita M, Mochio S, Suzuki M, Hirai T, Urashima M, Inoue K (2007b) Impaired cardiovascular autonomic function in Parkinson’s disease with visual hallucinations. Mov Disord 22:1510–1514PubMedCrossRefGoogle Scholar
  18. Riley DE, Chelimsky TC (2003) Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson’s disease. J Neurol Neurosurg Psychiatry 74:56–60PubMedCrossRefGoogle Scholar
  19. Schmidt C, Herting B, Prieur S, Junghanns S, Schweitzer K, Globas C, Schols L, Antoni S, Ferger D, Reichmann H, Wilhelm H, Berg D, Ziemssen T (2007) Pupil diameter in darkness differentiates progressive supranuclear palsy (PSP) from other extrapyramidal syndromes. Mov Disord 22:2123–2126PubMedCrossRefGoogle Scholar
  20. Schmidt C, Herting B, Prieur S, Junghanns S, Schweitzer K, Globas C, Schöls L, Reichmann H, Berg D, Ziemssen T (2008) Autonomic dysfunction in different subtypes of multiple system atrophy. Mov Disord 23:1766–1772PubMedCrossRefGoogle Scholar
  21. Wieling W, Karemaker JM (1999) Measurement of heart rate and blood pressure to evaluate disturbances in neurocardiovascular control. In: Mathias CJ, Bannister SR (eds) Autonomic failure. Oxford University Press, Oxford, pp 196–210Google Scholar
  22. Ziemssen T, Reichmann H (2007) Non-motor dysfunction in Parkinson’s disease. Parkinsonism Relat Disord 13:323–332PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • C. Schmidt
    • 1
  • B. Herting
    • 2
  • S. Prieur
    • 1
  • S. Junghanns
    • 2
  • K. Schweitzer
    • 3
  • C. Globas
    • 3
  • L. Schöls
    • 3
  • H. Reichmann
    • 2
  • D. Berg
    • 3
  • Tjalf Ziemssen
    • 1
  1. 1.Autonomic and Neuroendocrinological Laboratory, Department of NeurologyUniversity Clinic Carl Gustav Carus, Dresden University of TechnologyDresdenGermany
  2. 2.Movement Disorders Research Group, Department of NeurologyUniversity Clinic Carl Gustav Carus, Dresden University of TechnologyDresdenGermany
  3. 3.Department of Neurodegeneration, Center of Neurology, Hertie-Institute for Clinical Brain ResearchUniversity of TübingenTübingenGermany

Personalised recommendations